drugset
drugset / Trial / NCT05241912

Supernormal Oxygen Delivery for Patients With Severe Burns

NCT05241912 ↗

Phase 0 Unknown 100 enrolled Guangzhou Red Cross Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This is a randomized double-blinded study to investigate in which the groups are designated as the control group and the goal-directed fluid therapy group to further evaluate significant differences in rate of complications during burn surgery.

Timeline

Start
2022-02-28
Primary completion
2023-06-01
Completion
2023-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dobutamine Small molecule — —

Indications

No indication recorded.